Brian P. Murray is a litigation attorney in Holland & Knight's Chicago office and a member of the firm's Intellectual Property Group. Mr. Murray practices in the areas of intellectual property and technology-driven litigation, including cases arising under the Hatch-Waxman Act.

Mr. Murray has represented clients in patent litigation, including Hatch-Waxman patent litigation, concerning technological issues such as crystal forms (polymorphs), methods of treatment, molecules and chemical genus, medical devices and various formulations, including solid oral dosage forms, oral liquid dosage forms, injectables and transdermal/buccal dosage forms. Mr. Murray is experienced in all phases of litigation, ranging from pre-suit investigation to trial.

In addition to litigation, Mr. Murray counsels clients in a wide range of issues relating to pharmaceutical and biological technologies, including formulation development, product selection and regulatory issues before the U.S. Food and Drug Administration (FDA).

Prior to attending law school, Mr. Murray worked as a formulation development scientist at Caraco Pharmaceutical Laboratories and further gained experience in active pharmaceutical ingredient (API) and custom intermediate synthesis development at Fabbrica Italiana Sintetici S.p.A.


  • DePaul University College of Law, J.D., Certificate in Intellectual Property Law
  • University of Michigan, B.S.E., Chemical Engineering
Bar Admissions/Licenses
  • Illinois
Court Admissions
  • U.S. District Court for the Northern District of Illinois
  • U.S. Court of Appeals for the Federal Circuit
  • DePaul Journal of Art, Technology & Intellectual Property Law, Staff Writer, 2009-2010
Honors & Awards
  • CALI Excellence for the Future Award, Torts, DePaul University College of Law, 2008
  • CALI Excellence for the Future Award, Biotechnology Patent Strategies, DePaul University College of Law, 2010